CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
July 6th 2025
July 4th 2025
Fear is a powerful enemy of the mind but there’s another word that has the same power. That word is a six letter one, cancer.
June 25th 2025
June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.
June 24th 2025
If I’d gone flat after my mastectomy, I might be healthy now, but my breast implants led to more cancer, heart failure and years of pain.
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy.
What Breast Cancer Taught Me About Saying Yes to the Picture
After two bouts of breast cancer and a double mastectomy, I wish I had taken that photo at 34, just for me to remember the body I once had.
Faith, Friendship and Finding Purpose After Breast Cancer
After my breast cancer diagnosis, faith guided me through fear, and in passing on a blessed bracelet, I found healing and an unexpected reconnection.
Self-Advocacy Can Help Patients Navigate Cancer Treatment Challenges
Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive throughout chemotherapy.
Breaking Down the Impact of SERENA-6 for Some With Breast Cancer
Dr. Joshua K. Sabari and Dr. Julia E. McGuinness discussed the SERENA-6 trial and its outcomes for patients with ESR1-mutated HR+/HER2— breast cancer.
From Navigating the Unknown to Building a Movement: My DCIS Journey
The bad news is you have ductal carcinoma in situ. The good news is that DCIS is the best type of breast cancer to get.
Understanding the Importance of the DESTINY-Breast09 Trial in HER2+ Breast Cancer
Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic breast cancer should know.
Running a Race I Never Chose: Life During Cancer
I feel unprepared and overwhelmed after my breast cancer diagnosis, facing treatment like a race, hoping for the strength to reach the finish.
Where Compassion Meets Care in Breast Cancer
Sara Gideon, nurse practitioner, is a compassionate oncology nurse who supports patients with cancer, streamlines care and leads with dedication.
Survivorship, the Hardest Part After Cancer?
Survivorship after cancer can be harder than treatment. My daughter faces lasting side effects, fear, and uncertainty while building a life she hopes to live fully.
Beyond Treatment: How Support Groups Helped Me Embrace My New Normal
Joining support groups after cancer treatment helped me heal emotionally, connect with others who understood and embrace a new, meaningful normal.
A Letter to My 2009 Self, Newly Diagnosed With Breast Cancer
I survived breast cancer and medical trauma, but the road was brutal. Fifteen years later, I’m alive, scarred and still searching for peace.
Understanding Breast Cancer Biomarkers Drives Patient Treatment Decisions
Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2-negative disease.
The Gift of a Good Cancer Nurse
When it comes to living with cancer, your nurses make a difference.
Dealing with Insensitivity After Breast Cancer Surgery
Breast cancer surgery can disfigure the body in some way, and often the scars are more than skin deep, which may worsen by the actions of others.
Kisqali Benefit Lasts Across Age in Breast Cancer Subset
Kisqali plus aromatase inhibitor improved outcomes across age and menopausal status in early hormone receptor–positive, HER2-negative breast cancer.
Imlunestrant Alone or With Verzenios Improved PROs in Advanced Breast Cancer
Imlunestrant alone or in combination with Verzenios improved patient-reported outcomes in ER+, HER2– advanced breast cancer following endocrine therapy.
Initial Enhertu Combo Improves Survival in HER2+ Advanced Breast Cancer
Adding Enhertu to Perjeta improved time without cancer growth versus standard care in advanced HER2-positive breast cancer, as per data from DESTINY-Breast09.
Camizestrant and CDK4/6 Inhibition Benefits Outcomes in Breast Cancer Subgroups
Camizestrant and continued therapy with CDK4/6 inhibition benefits patients who present with ESR1-mutated, ER+, HER2– advanced breast cancer.
Vepdegestrant Boosts Outcomes in ESR1-Mutant ER+/HER2– Advanced Breast Cancer
Among patients with ESR1-mutant, ER+, HER2– advanced breast cancer, vepdegestrant improved survival without progression when compared with Faslodex.
What I Would Tell the Woman I Was Before Breast Cancer
After being diagnosed with breast cancer at 39, I learned to advocate for myself, transforming fear into fierce resolve and purpose through every step.
True Grit: The Spirit of an Extraordinary Healer
Heather Patenaude, B.S.N., RN, displays the highest level of technical skills necessary to provide compassionate care to her patients.
Making Something Positive out of Breast Cancer
After my breast cancer treatment, I started a clothing bank to give others free access to recovery items like post-surgery shirts and pillows.
Itovebi Triplet Combo Boosts Survival in HR+, HER2– Breast Cancer
Itovebi plus Ibrance and Faslodex improved overall survival in patients with PIK3CA-mutant, HR+, HER2–, endocrine-resistant breast cancer versus placebo.
Contemplating AI Assistance as a Cancer Survivor
When I saw a study about using AI facial recognition in cancer decision-making headlines, I decided to try my own informal, non-scientific experiment.
FDA’s ODAC Casts Votes on the Use of Certain Treatment Options in Cancer Care
The FDA'S ODAC has casted their votes on the use of certain treatments in both the relapsed/refractory DLBCL and myeloma patient populations, respectively.
The Unnamed Nurse who Saved My Life During Breast Cancer
I’ll never forget the unnamed nurse who stayed calm and gentle while treating me during a dangerous post-surgery infection that could have ended my life.
Samuraciclib Therapy Combo Shows Responses in HR+ Advanced Breast Cancer
Recent phase 2 data support combination treatment with samuraciclib for those with HR+ advanced breast cancer following prior CDK4/6 inhibitor therapy.
Understanding the Unique Task of Treating Older Patients With Breast Cancer
Dr. Hyman B. Muss discusses the unique challenges that older patients with breast cancer face during and after treatment for their disease.
Perjeta Regimen Improves Survival in HER2+ Early-Stage Breast Cancer
Treatment with Perjeta, Herceptin and chemotherapy post-surgery led to a significant overall survival benefit in HER2-positive early-stage breast cancer.
Lymphedema Makes Summer Preparations Challenging After Breast Cancer
Summer heat can worsen my lymphedema, but I’ve learned simple ways to stay cool, reduce swelling and protect my arms — here’s what helps me most.